In one paragraphArticle in Research square, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
17 authors.
Matthew A SchaichDepartment of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
William J NathanLaboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD, USA.
Raman van WeePhysical and Theoretical Chemistry, Department of Chemistry, Kavli Institute for Nanoscience Discovery, Dorothy Crowfoot Hodgkin Building, University of Oxford, South Parks Road, Oxford OX1 3QU, U.K.ORCID https://orcid.org/0000-0001-8941-3693 Louise MartinDepartment of Oncology, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, OX3 9DS, U.K.
Afaf El-SagheerSchool of Chemistry, University of Southampton, SO17 1BJ, U.K.
Philipp KukuraPhysical and Theoretical Chemistry, Department of Chemistry, Kavli Institute for Nanoscience Discovery, Dorothy Crowfoot Hodgkin Building, University of Oxford, South Parks Road, Oxford OX1 3QU, U.K.ORCID https://orcid.org/0000-0003-0136-7704 Joseph A NewmanCentre for Medicines Discovery, University of Oxford, NDMRB, Oxford, OX3 7DQ, U.K.
David M WilsonBiomedical Research Institute, Hasselt University, 3590 Diepenbeek, Belgium.
Funding
Watching cooperative interactions between base and nucleotide excision repair proteinsR35ES031638 · NIEHS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Bennett Van Houten · 2020 to 2026
$6.2MChimeraX -- Next Generation Visualization and Analysis Software for Multiscale ModelingR01GM129325 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FERRIN, THOMAS E · 2018 to 2025
$5.2MLumicks C-Trap Optical Tweezers with Confocal Fluorescence MicroscopeS10OD032158 · OD · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI VAN HOUTEN, BENNETT · 2023 to 2023
$552kDNA repair pathway coordination during damage processingF32ES034982 · NIEHS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SCHAICH, MATTHEW ALLEN · 2023 to 2025
$131kNIEHS NIH HHS F32 ES034982NIEHS NIH HHS R35 ES031638NIGMS NIH HHS R01 GM129325NIH HHS S10 OD032158Wellcome Trust
6 · The paper itselfAbstract
The Cockayne Syndrome B (CSB,
Identifiers
PMID41333433
PMCPMC12668182
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390